AURA BIOSCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
AURA BIOSCIENCES INC. - More news...
AURA BIOSCIENCES INC. - More news...
- Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma
- Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024
- Aura Biosciences to Participate in Upcoming Investor Conferences
- Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
- Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights
- Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
- Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
- Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
- Aura Biosciences to Participate in Upcoming Investor Conferences